Your browser doesn't support javascript.
loading
Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment.
Dwan, Toni Maree; Ownsworth, Tamara; Chambers, Suzanne; Walker, David G; Shum, David H K.
Afiliação
  • Dwan TM; School of Applied Psychology, Griffith Health Institute (Behavioural Basis of Health), Griffith University , Brisbane, QLD , Australia.
  • Ownsworth T; School of Applied Psychology, Griffith Health Institute (Behavioural Basis of Health), Griffith University , Brisbane, QLD , Australia.
  • Chambers S; School of Applied Psychology, Griffith Health Institute (Behavioural Basis of Health), Griffith University , Brisbane, QLD , Australia ; Cancer Council of Queensland , Brisbane, QLD , Australia.
  • Walker DG; NEWRO Foundation , Brisbane, QLD , Australia.
  • Shum DH; School of Applied Psychology, Griffith Health Institute (Behavioural Basis of Health), Griffith University , Brisbane, QLD , Australia.
Front Oncol ; 5: 56, 2015.
Article em En | MEDLINE | ID: mdl-25815271
ABSTRACT
Approaches to classifying neuropsychological impairment after brain tumor vary according to testing level (individual tests, domains, or global index) and source of reference (i.e., norms, controls, and pre-morbid functioning). This study aimed to compare rates of impairment according to different classification approaches. Participants were 44 individuals (57% female) with a primary brain tumor diagnosis (mean age = 45.6 years) and 44 matched control participants (59% female, mean age = 44.5 years). All participants completed a test battery that assesses pre-morbid IQ (Wechsler adult reading test), attention/processing speed (digit span, trail making test A), memory (Hopkins verbal learning test-revised, Rey-Osterrieth complex figure-recall), and executive function (trail making test B, Rey-Osterrieth complex figure copy, controlled oral word association test). Results indicated that across the different sources of reference, 86-93% of participants were classified as impaired at a test-specific level, 61-73% were classified as impaired at a domain-specific level, and 32-50% were classified as impaired at a global level. Rates of impairment did not significantly differ according to source of reference (p > 0.05); however, at the individual participant level, classification based on estimated pre-morbid IQ was often inconsistent with classification based on the norms or controls. Participants with brain tumor performed significantly poorer than matched controls on tests of neuropsychological functioning, including executive function (p = 0.001) and memory (p < 0.001), but not attention/processing speed (p > 0.05). These results highlight the need to examine individuals' performance across a multi-faceted neuropsychological test battery to avoid over- or under-estimation of impairment.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article